Here are some of the top stories today that affecting key drug and biotech stocks: GlaxoSmithKline (NYSE: GSK) reorganized its corporate structure, increasing focus on emerging markets such as China,...
Biolase, GNC Holdings, Scorpio Tankers, and Finisar all posted new 52-week lows on Monday.
JA Solar Holdings Co., Ltd. (NASDAQ: JASO) and MEMC Electronic Materials Inc. (NYSE: WFR) are offering some positive support to each other after announcing a joint venture agreement.  The J-V...
Markets in Europe were down slightly at 6.45 AM New York time. The FTSE was off 4% to 5,760. BP (NYSE: BP) was up 1% to 552.5. GlaxoSmithKline (NYSE: GSK) was up 2.5% to 1,097. The DAXX was down .2%...
It appears that the talk about China’s Bright Food Group Co. wanting to buy US nutritional retailer GNC Holdings Inc. is about to prove true. The Wall Street Journal is citing “people familiar...
Source: ThinkstockGNC Holdings Inc. (NYSE: GNC) is getting its turn in the negative news mill over the quality and legality of supplement sales. As you might have guessed, it is not in a positive...
No matter what kind of cargo a shipping company moves, that company is likely to be in some financial distress. Rates for moving containers, dry bulk, and oil are all way down as the global economy...
Investors are bracing for billions of dollars in losses due to lawsuits filed over the heartburn drug Zantac.
Updated throughout the day.Samsung will try to push cellphone unit sales up 18% next year to 330 million (Electronic Times) BP plc (NYSE: BP) may sell its North Shore assets (Bloomberg)Blackstone...
Source: Jon OggJunk bonds, or those high-yield bonds which are under BBB- at S&P or under Baa3 at Moody’s, have seen one massive rally since the lows of the summer.  Some may wonder if these have...
We are only featuring a few key day trader and active trader stocks early this morning.  We have links through to more data and analysis with links on each stock over at VSInvestor.com: Genworth...
PG&E, Edison International, GNC Holdings, and PPL Corp. all posted new 52-week lows Thursday.
Biogen Idec (NASDAQ: BIIB) is sliding marginally despite reported earnings today that showed a 23% increase in earnings riding on sales growth on Avonex and Rituxan. The earnings beat estimates and...
Bitdeer Technologies is joining forces with Bhutan’s sovereign investment arm to establish a $500 million fund.
Source: GileadGilead Sciences, Inc. (NASDAQ: GILD) has a product chest that includes Atripla, Truvada, Viread, Complera/Eviplera, and Emtriva for the treatment of HIV infection in adults.  While...